News for 'pharmaceutical industry'

'Advisable to invest in markets now?'

'Advisable to invest in markets now?'

Rediff.com7 May 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Ask Ajit: 'Want to invest Rs 2 lakhs, please advise'

Rediff.com22 Nov 2021

Ajit Mishra, vice president, Research, Religare Broking, answers your queries.

Sensex ends above 29,000; SBI jumps 8%, M&M up 5%

Sensex ends above 29,000; SBI jumps 8%, M&M up 5%

Rediff.com13 Feb 2015

The Sensex ended 290 points higher at 29,095 mark and the Nifty gained 94 points to close at 8,806 levels.

Ranbaxy Q3 net loss widens to Rs 1,029 cr on forex woes

Ranbaxy Q3 net loss widens to Rs 1,029 cr on forex woes

Rediff.com28 Jan 2015

Ranbaxy Laboratories on Wednesday reported widening of its consolidated net loss to Rs 1,029.72 crore (Rs 10.29 billion) for the third quarter ended December 31, 2014

Hero MotoCorp's Pawan Munjal is highest paid director

Hero MotoCorp's Pawan Munjal is highest paid director

Rediff.com25 Nov 2015

Hero MotoCorp's promoter Pawan Munjal emerged as the highest paid director.

'We have to do everything to avoid a super spreader event'

'We have to do everything to avoid a super spreader event'

Rediff.com1 Jan 2022

'Health will continue to be at the centre of the government's attention as it underpins economic recovery and our collective well being.'

Trump has not been tested for coronavirus: White House

Trump has not been tested for coronavirus: White House

Rediff.com10 Mar 2020

Trump was in contact with multiple lawmakers who have since gone into self-imposed quarantine.

India's exports dip 5.4% in Oct, trade deficit narrows

India's exports dip 5.4% in Oct, trade deficit narrows

Rediff.com3 Nov 2020

After recording positive growth in September, India's exports declined 5.4 per cent to $24.82 billion in October on account of dip in shipments of petroleum products, gems and jewellery, leather, and engineering goods. Trade deficit in October narrowed to $8.78 billion as against $11.76 billion, as imports also fell 11.56 per cent to $33.6 billion during the month under review.

New pricing policy to hit pharma growth a tad

New pricing policy to hit pharma growth a tad

Rediff.com11 Dec 2013

According to industry estimates, the sector's revenue would increase eight-10 per cent in 2013-14, against 12 per cent in 2012-13.

'Rate hike will throw lot of people out from jobs'

'Rate hike will throw lot of people out from jobs'

Rediff.com23 May 2022

'Nobody is talking about the inequality that is going to come.'

Sensex rises for 3rd day, gains 142 points

Sensex rises for 3rd day, gains 142 points

Rediff.com10 Aug 2020

L&T was the top gainer in the Sensex pack, rallying 4.81 per cent, followed by M&M, Sun Pharma, Tech Mahindra, NTPC, SBI, ICICI Bank and Titan.

Tatas, Adani, Ambanis in scramble for super app

Tatas, Adani, Ambanis in scramble for super app

Rediff.com8 Nov 2021

The groups plan to take on well-entrenched players like Amazon, Flipkart, and Paytm by merging their offline businesses with e-commerce initiatives.

High commodity prices hit India Inc's profits, margins

High commodity prices hit India Inc's profits, margins

Rediff.com17 Aug 2021

After the hit of the pandemic, India Inc is now worried about the adverse impact of inflation and higher commodity prices on their revenues and margins. The inflation scare is the strongest among manufacturers of consumer goods such as automobiles, consumer durables, and fast-moving capital goods (FMCG). Companies across sectors fear they will not be able to pass on the hike in input costs to their consumers due to weak demand, which, in turn, would lead to a hit on margins and profitability in the forthcoming quarters.

Markets pause after record breaking spree on profit taking

Markets pause after record breaking spree on profit taking

Rediff.com20 Aug 2014

The Nifty had hit its third successive record high of 7,922.70 today.

Pharma outsourcing to cross $2.3 bn by 2010

Pharma outsourcing to cross $2.3 bn by 2010

Rediff.com14 Aug 2009

Riding over lower manufacturing cost coupled with availability of quality manpower with technical capabilities, the Indian pharmaceutical outsourcing industry is expected to reach $2.3 billion by the end of 2010, according to a report.

Sensex rebounds; zooms 429 points at close

Sensex rebounds; zooms 429 points at close

Rediff.com19 Feb 2020

On the Sensex chart, Bajaj Finance, HUL, RIL, ONGC and HDFC emerged as the top gainers.

ASK AJIT: Stocks To Buy, Hold, Sell

ASK AJIT: Stocks To Buy, Hold, Sell

Rediff.com11 Mar 2022

Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Reliance Retail buys majority stake in Netmeds for Rs 620 cr

Rediff.com19 Aug 2020

Reliance Retail Ventures Ltd has acquired a majority equity stake in digital pharma market place Netmeds for a cash consideration of around Rs 620 crore, Reliance Industries said in a late night statement on Tuesday.

The bizarre tale of Cairn retro tax

The bizarre tale of Cairn retro tax

Rediff.com6 Mar 2022

The levy of retrospective tax on the UK's Cairn Energy Plc is a tale of bizarre twists and turns that saw its attached shares being sold in May 2018 amid the passing of the baton from a full-time finance minister to interim one and the talks at the highest level to resolve the dispute, to claims that levy of back taxes was a result of an investigation into Panama Papers leak. The government late last month refunded about Rs 7,900 crore it had collected from selling residual shares of the British firm in its erstwhile India unit, seizing dividend and withholding tax refunds, to settle an eight-year-old dispute that had tarred the country's reputation as an investment destination. But, this did not come about easily. For seven years, the establishment vehemently justified in courts and outside seeking of Rs 10,247 crore in back taxes plus interest and penalty from a firm that gave India its biggest onshore oil discovery.

How India can survive the Trump years

How India can survive the Trump years

Rediff.com30 Jan 2017

Devangshu Datta highlights the silver lining for the long-term investor.

John le Carr's matchless legacy

John le Carr's matchless legacy

Rediff.com27 Dec 2020

'Le Carré's spies were nothing like the exotic Kim of Kipling or the caricature that is James Bond.' 'Driven by a simple patriotism, held back by incompetence and politics, his characters use deceit and treachery to win their morally Pyrrhic victories,' notes P Rajendran.

Pharma, engineering power exports to 6.16% y-on-y growth in Jan

Pharma, engineering power exports to 6.16% y-on-y growth in Jan

Rediff.com15 Feb 2021

Trade deficit during the month narrowed to USD 14.54 billion from USD 15.3 billion in January 2020. It was USD 15.44 billion in December 2020.

Exports fall for 6th straight month; down over 12%

Exports fall for 6th straight month; down over 12%

Rediff.com15 Sep 2020

Imports too declined 26 per cent to $29.47 billion in August, leaving a trade deficit of $6.77 billion.

India Inc's foreign investment doubles to $3.02 bn in Sep

India Inc's foreign investment doubles to $3.02 bn in Sep

Rediff.com12 Oct 2014

The investments were a mix of issuance of guarantees ($2.53 billion), loan ($257.60 million) and of equity ($232.59 million).

7 jobs in DEMAND

7 jobs in DEMAND

Rediff.com27 Jan 2021

There will be a huge market for healthcare professionals, data and security experts and digital marketers, says Navneet Singh, founder, Avsar HR Services.

In 3 years, RIL forked out $ 3.1 billion on acquisitions

In 3 years, RIL forked out $ 3.1 billion on acquisitions

Rediff.com20 Aug 2020

The acquisitions were made in areas which are closely related to Reliance's key businesses - telecom, internet, retail, digital, media, education, digital, chemicals and energy.

India Inc's tryst with China

India Inc's tryst with China

Rediff.com12 May 2015

India seeks greater market access for its products including textiles, pharmaceuticals and bovine meat.

Cracking India's coconut puzzle

Cracking India's coconut puzzle

Rediff.com24 Jul 2017

Value addition is one of the chief requirements for coconut to become a commercially lucrative crop. Surinder Sud reports.

Hiring activity jumps 15% in June

Hiring activity jumps 15% in June

Rediff.com8 Jul 2021

Hiring activity in the country, which was hit by the second COVID wave, bounced back with a 15 per cent growth in June compared to May, according to a report. The activity was led by the IT-software/software services sector. The latest Naukri JobSpeak report on Thursday said that India's hiring trends grew 15 per cent in June with 2,359 job postings from 2,047 in May.

Exports fall 36% in May, trade deficit narrows to $3.15 bn

Exports fall 36% in May, trade deficit narrows to $3.15 bn

Rediff.com15 Jun 2020

Barring rice, spices, iron ore and pharmaceuticals, all the remaining 26 key sectors registered negative growth in May. Imports too plunged 51 per cent to $22.2 billion in May.

Geneticist Raj Barathur passes into the ages

Geneticist Raj Barathur passes into the ages

Rediff.com27 Aug 2020

Raj Barathur -- Indian American entrepreneur, geneticist, professor and biopharmaceutical industry leader -- stayed the course even when diagnosed with lung cancer

Finmin reimposes spending curbs on ministries, depts for Q2

Finmin reimposes spending curbs on ministries, depts for Q2

Rediff.com1 Jul 2021

The finance ministry on Wednesday reimposed expenditure curbs on ministries and government departments for July-September quarter. There will be no spending restrictions on the ministries of health, rural development, agriculture, MSME (micro, small and medium enterprises) and railways as part of a two-pronged strategy. "The existing guidelines for expenditure control have been reviewed. "Keeping in view the evolving situation arising out of Covid-19 and anticipated cash position of the government, it is felt essential to regulate Quarterly Expenditure Plan (QEP)/Monthly Expenditure Plan (MEP) of specific ministries/departments for July-September, 2021," the Department of Economic Affairs in the finance ministry said in a notification.

India-made Remdesivir may come out in 10 days

India-made Remdesivir may come out in 10 days

Rediff.com19 Jun 2020

The antiviral drug may cost around Rs 55,000 for an 11-dose course, or Rs 5,000 per injection -- much less than the price of imports from Bangladesh, reports Sohini Das.

Restarting your career in the pandemic? 5 TIPS

Restarting your career in the pandemic? 5 TIPS

Rediff.com10 May 2021

The first step? Get in touch with past employers and colleagues to see if there are any opportunities, advises Ravish Agrawal, founder and CEO, Able Jobs.

India pays Cairn Rs 7,900 cr to settle retro tax dispute

India pays Cairn Rs 7,900 cr to settle retro tax dispute

Rediff.com24 Feb 2022

The Indian government has paid Cairn Energy Plc Rs 7,900 crore to refund taxes it had collected to enforce a retrospective tax demand, ending a seven-year-old dispute that had tarred the country's image as an investment destination. The company, which is now known as Capricorn Energy PLC, in a statement said it has received "net proceeds of $1.06 billion", of which nearly 70 per cent will be returned to the shareholders. The tax department had used a 2012 legislation, which gave it powers to go back 50 years and slap capital gains levies wherever ownership had changed hands overseas but business assets were in India, to seek Rs 10,247 crore in taxes from Cairn.

Indian pharma's Trump fears

Indian pharma's Trump fears

Rediff.com1 Feb 2017

Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports.

India's richest club sees nine new entrants; Ambani still No 1

India's richest club sees nine new entrants; Ambani still No 1

Rediff.com9 Oct 2020

Half of the nation's 100 richest saw gains rising a collective 14% to $517.5 billion, says Forbes. Forbes released 2020's top 100 richest Indians on Thursday, which included newcomers, Sanjeev Bikhchandani, co-founder of Info Edge (India), who owns popular job and property websites; siblings Nithin and Nikhil Kamath, co-founders of discount stock brokerage Zerodha Broking, and three specialty chemicals producers - Vinod Saraf, founder of Vinati Organics, Arun Bharat Ram, the patriarch of SRF, and brothers Chandrakant and Rajendra Gogri of Aarti Industries. Other newcomers included Delhi-based brothers Ramesh Kumar and Mukand Lal Dua of Relaxo Footwears, which owns affordable footwear brands; dairyman, R G Chandramogan of Hatsun Agro; Premchand Godha, who chairs IPCA Laboratories, manufacturing formulations, bulk drugs and drug intermediates; G Rajendran, founder of jewellery chain, GRT Jewellers.

No respite for banks; NPAs seen to rise in first half of 2021

No respite for banks; NPAs seen to rise in first half of 2021

Rediff.com17 Mar 2021

Asset quality of banks, which saw some improvement in the second half of 2020, is likely to worsen during the first six months of 2021, according to a survey. The findings are part of the 12th round of bankers' survey carried out by FICCI-IBA between July and December 2020. The survey was conducted on 20 banks, including public sector, private sector and foreign banks, representing about 59 per cent of the banking industry, as classified by asset size.

Local drug makers worried as regulators start working together

Local drug makers worried as regulators start working together

Rediff.com26 Dec 2013

Various domestic companies such as Ranbaxy, Wockhardt and Agila Specialities recently came under the US FDA scanner for lapse in manufacturing practices.

Ranbaxy staff get pay-cut shield in Sun buyout

Ranbaxy staff get pay-cut shield in Sun buyout

Rediff.com20 Oct 2014

Sun maintained it would retain the best of both organisations to build a global pharma company.